{"transactions":[{"id":733473,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Common Stock","published_at":"2026-06-17T20:15:22.000Z","date":"2026-06-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":9545,"price":7.18,"value":68533.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."}],"balance_after":285512,"source":{"system":"sec-edgar","filing":"0001552047-26-000006","document":"form4-06172026_040614.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000155204726000006/form4-06172026_040614.xml","form_type":"4"}},{"id":767513,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-05-21T21:41:33.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":217338,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest in 48 equal monthly installments commencing on May 19, 2026, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date."}],"balance_after":217338,"derivative":{"exercise_price":5.54,"expiration_date":"2036-05-18","underlying":"Common Stock","underlying_shares":217338},"source":{"system":"sec-edgar","filing":"0001552047-26-000004","document":"form4-05212026_090529.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000155204726000004/form4-05212026_090529.xml","form_type":"4"}},{"id":767512,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Common Stock","published_at":"2026-05-21T21:41:33.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":157943,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") grant. The RSUs vest in eight equal installments with the first installment vesting on June 15, 2026 and the remaining seven installments vesting in six month increments commencing on November 15, 2026, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":295057,"source":{"system":"sec-edgar","filing":"0001552047-26-000004","document":"form4-05212026_090529.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000155204726000004/form4-05212026_090529.xml","form_type":"4"}},{"id":774385,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Common Stock","published_at":"2026-05-18T20:30:08.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":7320,"price":5.82,"value":42602.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."}],"balance_after":137114,"source":{"system":"sec-edgar","filing":"0001552047-26-000002","document":"form4-05182026_040503.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000155204726000002/form4-05182026_040503.xml","form_type":"4"}},{"id":995236,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Common Stock","published_at":"2025-11-19T00:00:08.000Z","date":"2025-11-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":5997,"price":6.26,"value":37541.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective October 17, 2025, the Issuer effected a 1-for-20 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split."}],"balance_after":144434,"source":{"system":"sec-edgar","filing":"0001552047-25-000003","document":"form4-11182025_071104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000155204725000003/form4-11182025_071104.xml","form_type":"4"}},{"id":1107555,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Common Stock","published_at":"2025-06-17T22:45:09.000Z","date":"2025-06-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":35784,"price":0.51,"value":18249.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."}],"balance_after":3008622,"source":{"system":"sec-edgar","filing":"0001415889-25-017599","document":"form4-06172025_060604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000141588925017599/form4-06172025_060604.xml","form_type":"4"}},{"id":1131564,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-05-28T20:30:20.000Z","date":"2025-05-23","kind":"grant","planned":false,"acquired":true,"shares":712792,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest in 48 equal monthly installments commencing on June 23, 2025, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date."}],"balance_after":712792,"derivative":{"exercise_price":0.51,"expiration_date":"2035-05-22","underlying":"Common Stock","underlying_shares":712792},"source":{"system":"sec-edgar","filing":"0001415889-25-014713","document":"form4-05282025_040507.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000141588925014713/form4-05282025_040507.xml","form_type":"4"}},{"id":1131563,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Common Stock","published_at":"2025-05-28T20:30:20.000Z","date":"2025-05-23","kind":"grant","planned":false,"acquired":true,"shares":505251,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") grant. The RSUs vest in eight equal installments with the first installment vesting on June 15, 2025 and the remaining seven installments vesting in six month increments commencing on November 15, 2025, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":3044406,"source":{"system":"sec-edgar","filing":"0001415889-25-014713","document":"form4-05282025_040507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000141588925014713/form4-05282025_040507.xml","form_type":"4"}},{"id":1142001,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Common Stock","published_at":"2025-05-19T22:00:36.000Z","date":"2025-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":167085,"price":0.55,"value":91896.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."}],"balance_after":2539155,"source":{"system":"sec-edgar","filing":"0001415889-25-013692","document":"form4-05192025_060507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000141588925013692/form4-05192025_060507.xml","form_type":"4"}},{"id":1361412,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Common Stock","published_at":"2024-11-18T21:15:12.000Z","date":"2024-11-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":187665,"price":0.28,"value":52546.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."}],"balance_after":2706240,"source":{"system":"sec-edgar","filing":"0001415889-24-027077","document":"form4-11182024_041107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000141588924027077/form4-11182024_041107.xml","form_type":"4"}},{"id":1474704,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Common Stock","published_at":"2024-06-18T20:15:42.000Z","date":"2024-06-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":80785,"price":0.39,"value":31506.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."}],"balance_after":2893905,"source":{"system":"sec-edgar","filing":"0001415889-24-017394","document":"form4-06182024_040625.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000141588924017394/form4-06182024_040625.xml","form_type":"4"}},{"id":1501581,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Common Stock","published_at":"2024-05-24T20:46:19.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":1135604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") grant. The RSUs vest in eight equal installments with the first installment vesting on June 15, 2024 and the remaining seven installments vesting in six month increments commencing on November 15, 2024, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":2974690,"source":{"system":"sec-edgar","filing":"0001415889-24-014544","document":"form4-05242024_040543.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000141588924014544/form4-05242024_040543.xml","form_type":"4"}},{"id":1510607,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Common Stock","published_at":"2024-05-17T20:15:23.000Z","date":"2024-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":108100,"price":0.5,"value":54050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."}],"balance_after":1839086,"source":{"system":"sec-edgar","filing":"0001415889-24-013482","document":"form4-05172024_040516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000141588924013482/form4-05172024_040516.xml","form_type":"4"}},{"id":1736108,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Common Stock","published_at":"2023-11-17T21:56:07.000Z","date":"2023-11-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":163319,"price":0.61,"value":99624.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."}],"balance_after":1947186,"source":{"system":"sec-edgar","filing":"0001209191-23-055774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000120919123055774/doc4.xml","form_type":"4"}},{"id":1848928,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Common Stock","published_at":"2023-06-20T22:12:02.000Z","date":"2023-06-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":51276,"price":0.77,"value":39482.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."}],"balance_after":2110505,"source":{"system":"sec-edgar","filing":"0001209191-23-038581","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000120919123038581/doc4.xml","form_type":"4"}},{"id":1888430,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Common Stock","published_at":"2023-05-18T00:49:07.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":782089,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an RSU grant. The RSUs vest in eight equal installments with the first installment vesting on June 15, 2023 and the remaining seven installments vesting in six month increments commencing on November 15, 2023, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":2161781,"source":{"system":"sec-edgar","filing":"0001209191-23-030451","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000120919123030451/doc4.xml","form_type":"4"}},{"id":1888429,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Common Stock","published_at":"2023-05-18T00:49:07.000Z","date":"2023-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":137927,"price":0.74,"value":102065.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units (\"RSUs\")."}],"balance_after":1379692,"source":{"system":"sec-edgar","filing":"0001209191-23-030451","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000120919123030451/doc4.xml","form_type":"4"}},{"id":1888428,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Common Stock","published_at":"2023-05-18T00:49:07.000Z","date":"2022-11-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":104306,"price":1.25,"value":130382.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units (\"RSUs\")."}],"balance_after":1517619,"source":{"system":"sec-edgar","filing":"0001209191-23-030451","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000120919123030451/doc4.xml","form_type":"4"}},{"id":1888427,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Common Stock","published_at":"2023-05-18T00:49:07.000Z","date":"2022-06-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":26105,"price":0.97,"value":25321.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units (\"RSUs\")."}],"balance_after":1621925,"source":{"system":"sec-edgar","filing":"0001209191-23-030451","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000120919123030451/doc4.xml","form_type":"4"}},{"id":2250905,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Common Stock","published_at":"2022-05-31T22:20:48.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":431035,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents an RSU grant. The RSUs vest in eight equal installments with the first installment vesting on June 15, 2022 and the remaining\nseven installments vesting in six month increments commencing on November 15, 2022, subject to the Reporting Person's continuous service with the\nIssuer as of the applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1648030,"source":{"system":"sec-edgar","filing":"0001209191-22-032953","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000120919122032953/doc4.xml","form_type":"4"}},{"id":2250904,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Common Stock","published_at":"2022-05-31T22:20:48.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a Restricted Stock Unit (\"RSU\") grant. The RSUs vest on May 15, 2023, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1216995,"source":{"system":"sec-edgar","filing":"0001209191-22-032953","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000120919122032953/doc4.xml","form_type":"4"}},{"id":2265223,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Common Stock","published_at":"2022-05-19T00:06:55.000Z","date":"2022-05-16","kind":"tax_withholding","acquired":false,"shares":45430,"price":1.13,"value":51335.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."}],"balance_after":1171995,"source":{"system":"sec-edgar","filing":"0001209191-22-030280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000120919122030280/doc4.xml","form_type":"4"}},{"id":2397195,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Common Stock","published_at":"2022-02-15T00:45:33.000Z","date":"2022-02-11","kind":"sale","acquired":false,"shares":143126,"price":2.46,"value":352089.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold to cover tax obligations upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.575 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1217425,"source":{"system":"sec-edgar","filing":"0001209191-22-009555","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000120919122009555/doc4.xml","form_type":"4"}},{"id":2397194,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Common Stock","published_at":"2022-02-15T00:45:33.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":255287,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a performance-based restricted stock unit (\"RSU\") award, which represent a contingent right to receive one share of the Issuer's common stock and vest upon the achievement of certain performance targets, subject to the Reporting Person's continuous service through the vesting events. 100% of the RSUs vested on February 10, 2022 upon the achievement of the performance vesting criteria."}],"balance_after":1360551,"source":{"system":"sec-edgar","filing":"0001209191-22-009555","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000120919122009555/doc4.xml","form_type":"4"}},{"id":2504375,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Common Stock","published_at":"2021-11-18T14:26:58.000Z","date":"2021-11-15","kind":"tax_withholding","acquired":false,"shares":46426,"price":3.8,"value":176418.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."}],"balance_after":1105264,"source":{"system":"sec-edgar","filing":"0001209191-21-065382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000120919121065382/doc4.xml","form_type":"4"}},{"id":2665644,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Common Stock","published_at":"2021-06-16T22:15:36.000Z","date":"2021-06-15","kind":"tax_withholding","acquired":false,"shares":10899,"price":3.69,"value":40217.31,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units."}],"balance_after":1151690,"source":{"system":"sec-edgar","filing":"0001209191-21-041048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000120919121041048/doc4.xml","form_type":"4"}},{"id":2692688,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Common Stock","published_at":"2021-05-28T01:33:27.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":306451,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a RSU grant. The RSUs vest in eight equal installments with the first installment vesting on June 15, 2021 and the remaining RSUs\nvesting in six month increments commencing on November 15, 2021, subject to the Reporting Person's continuous service with the Issuer as of\nthe applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1162589,"source":{"system":"sec-edgar","filing":"0001209191-21-036389","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000120919121036389/doc4.xml","form_type":"4"}},{"id":2692687,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Corp. Development Advisor"}}],"security":"Common Stock","published_at":"2021-05-28T01:33:27.000Z","date":"2021-05-15","kind":"tax_withholding","acquired":false,"shares":34710,"price":1.92,"value":66643.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units (\"RSUs\")."}],"balance_after":856138,"source":{"system":"sec-edgar","filing":"0001209191-21-036389","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552047/000120919121036389/doc4.xml","form_type":"4"}},{"id":459306,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock","published_at":"2014-11-19T21:20:46.000Z","date":"2014-11-17","kind":"gift","acquired":false,"shares":410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Horton's company approved trading plan under Rule 10b5-1."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents two gifts made to a charity and a charity donor-advised fund."}],"balance_after":72053,"source":{"system":"sec-edgar","filing":"0001209191-14-070000","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114070000/doc4.xml","form_type":"4"}},{"id":460120,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock","published_at":"2014-11-03T22:43:46.000Z","date":"2014-10-30","kind":"grant","acquired":true,"shares":40000,"price":0.01,"value":400.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Performance-based retention award that will vest if performance objectives are achieved prior to November 15, 2019.  The award will vest on October 30, 2017 (or, if later, the day following the earnings release for the third quarter of 2017) if the Company achieves positive EBITDA for the 12-month period ending September 30, 2017.   Between January 1, 2018 and November 15, 2019, if the Company achieves positive EBITDA for a 12-month period ending on a calendar quarter, the award will vest on the day following  the applicable earnings release."}],"balance_after":72463,"source":{"system":"sec-edgar","filing":"0001209191-14-065909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114065909/doc4.xml","form_type":"4"}},{"id":461065,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2014-10-01T21:18:44.000Z","date":"2014-09-30","kind":"exercise","acquired":false,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests in 16 quarterly installments from 06/11/2012."}],"balance_after":36000,"derivative":{"exercise_price":55.83,"expiration_date":"2022-06-10","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001209191-14-060597","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114060597/doc4.xml","form_type":"4"}},{"id":461064,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock","published_at":"2014-10-01T21:18:44.000Z","date":"2014-09-30","kind":"sale","acquired":false,"shares":7400,"price":113.91,"value":842934.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Horton's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Horton undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $113.91 (range $113.62 to $114.41)."}],"balance_after":32463,"source":{"system":"sec-edgar","filing":"0001209191-14-060597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114060597/doc4.xml","form_type":"4"}},{"id":461063,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock","published_at":"2014-10-01T21:18:44.000Z","date":"2014-09-30","kind":"sale","acquired":false,"shares":9601,"price":113.1,"value":1085873.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Horton's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Horton undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $113.10 (range $112.61 to $113.60)."}],"balance_after":39863,"source":{"system":"sec-edgar","filing":"0001209191-14-060597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114060597/doc4.xml","form_type":"4"}},{"id":461062,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock","published_at":"2014-10-01T21:18:44.000Z","date":"2014-09-30","kind":"sale","acquired":false,"shares":14286,"price":112.22,"value":1603174.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Horton's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Horton undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $112.22 (range $111.61 to $112.60)."}],"balance_after":49464,"source":{"system":"sec-edgar","filing":"0001209191-14-060597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114060597/doc4.xml","form_type":"4"}},{"id":461061,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock","published_at":"2014-10-01T21:18:44.000Z","date":"2014-09-30","kind":"sale","acquired":false,"shares":4713,"price":111.33,"value":524698.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Horton's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $111.33 (range $110.61 to $111.60)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Horton undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":63750,"source":{"system":"sec-edgar","filing":"0001209191-14-060597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114060597/doc4.xml","form_type":"4"}},{"id":461060,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock","published_at":"2014-10-01T21:18:44.000Z","date":"2014-09-30","kind":"exercise","acquired":true,"shares":36000,"price":55.83,"value":2009880.0,"ownership":{"direct":true},"balance_after":68463,"source":{"system":"sec-edgar","filing":"0001209191-14-060597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114060597/doc4.xml","form_type":"4"}},{"id":463200,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2014-07-17T22:23:15.000Z","date":"2014-07-15","kind":"grant","acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 16 quarterly installments from 07/15/2014."}],"balance_after":34000,"derivative":{"exercise_price":96.87,"expiration_date":"2024-07-14","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001209191-14-047899","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114047899/doc4.xml","form_type":"4"}},{"id":463506,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2014-07-03T20:42:33.000Z","date":"2014-07-01","kind":"exercise","acquired":false,"shares":28321,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/05/2013."}],"balance_after":62304,"derivative":{"exercise_price":45.11,"exercise_date":"2013-05-05","expiration_date":"2023-02-04","underlying":"Common Stock","underlying_shares":28321},"source":{"system":"sec-edgar","filing":"0001209191-14-046017","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114046017/doc4.xml","form_type":"4"}},{"id":463505,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock","published_at":"2014-07-03T20:42:33.000Z","date":"2014-07-01","kind":"sale","acquired":false,"shares":27877,"price":95.28,"value":2656120.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Horton's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Horton undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $95.28 (range $94.79 to $95.66)."}],"balance_after":32463,"source":{"system":"sec-edgar","filing":"0001209191-14-046017","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114046017/doc4.xml","form_type":"4"}},{"id":463504,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock","published_at":"2014-07-03T20:42:33.000Z","date":"2014-07-01","kind":"sale","acquired":false,"shares":2257,"price":94.49,"value":213263.93,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Horton's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $94.49 (range $93.79 to $94.78)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Horton undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":60340,"source":{"system":"sec-edgar","filing":"0001209191-14-046017","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114046017/doc4.xml","form_type":"4"}},{"id":463503,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock","published_at":"2014-07-03T20:42:33.000Z","date":"2014-07-01","kind":"exercise","acquired":true,"shares":28321,"price":45.11,"value":1277560.31,"ownership":{"direct":true},"balance_after":62597,"source":{"system":"sec-edgar","filing":"0001209191-14-046017","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114046017/doc4.xml","form_type":"4"}},{"id":469339,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2014-02-07T21:04:48.000Z","date":"2014-02-05","kind":"grant","acquired":true,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 16 quarterly installments from 02/05/2014."}],"balance_after":51000,"derivative":{"exercise_price":77.31,"expiration_date":"2024-02-04","underlying":"Common Stock","underlying_shares":51000},"source":{"system":"sec-edgar","filing":"0001209191-14-008354","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114008354/doc4.xml","form_type":"4"}},{"id":469338,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock","published_at":"2014-02-07T21:04:48.000Z","date":"2014-02-05","kind":"grant","acquired":true,"shares":17250,"price":0.01,"value":172.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant under 2006 Stock and Option Plan, vesting on 2/5/2018, subject to (i) acceleration of 50% of shares upon (a) reaching a specified net product sales level over a one-year period for a combination regimen that includes ivacaftor and a CFTR corrector or (b) dosing of the first patient in the first clinical trial to evaluate a second-generation CFTR corrector compound and (ii) acceleration of 50% of shares upon (a) dosing of the first patient in a pivotal trial for a regimen including VX-661 or a specified cancer compound or (b) reaching a specified net product sales level over a one-year period for all our products."}],"balance_after":33874,"source":{"system":"sec-edgar","filing":"0001209191-14-008354","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114008354/doc4.xml","form_type":"4"}},{"id":471352,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock","published_at":"2013-12-12T22:49:59.000Z","date":"2013-12-12","kind":"sale","acquired":false,"shares":4532,"price":65.46,"value":296664.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Horton's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $65.46 (range $65.05 to $65.91)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Horton undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":16624,"source":{"system":"sec-edgar","filing":"0001209191-13-056696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919113056696/doc4.xml","form_type":"4"}},{"id":475551,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Stock Option","published_at":"2013-08-01T20:10:30.000Z","date":"2013-07-30","kind":"grant","acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 16 quarterly installments from 07/30/2013."}],"balance_after":34000,"derivative":{"exercise_price":83.36,"expiration_date":"2023-07-29","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001209191-13-038681","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919113038681/doc4.xml","form_type":"4"}},{"id":476026,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock","published_at":"2013-07-10T20:44:02.000Z","date":"2013-07-08","kind":"sale","acquired":false,"shares":300,"price":81.82,"value":24546.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Horton's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Horton undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $81.82 (range $81.61 to $82.19)."}],"balance_after":20676,"source":{"system":"sec-edgar","filing":"0001209191-13-036101","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919113036101/doc4.xml","form_type":"4"}},{"id":476025,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock","published_at":"2013-07-10T20:44:02.000Z","date":"2013-07-08","kind":"sale","acquired":false,"shares":1513,"price":80.5,"value":121796.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Horton's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $80.50 (range $80.17 to $80.84)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Horton undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":20976,"source":{"system":"sec-edgar","filing":"0001209191-13-036101","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919113036101/doc4.xml","form_type":"4"}},{"id":482336,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2013-02-07T22:31:07.000Z","date":"2013-02-05","kind":"grant","acquired":true,"shares":90625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/05/2013."}],"balance_after":90625,"derivative":{"exercise_price":45.11,"expiration_date":"2023-02-04","underlying":"Common Stock","underlying_shares":90625},"source":{"system":"sec-edgar","filing":"0001209191-13-007125","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919113007125/doc4.xml","form_type":"4"}},{"id":482335,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock","published_at":"2013-02-07T22:31:07.000Z","date":"2013-02-05","kind":"grant","acquired":true,"shares":12084,"price":0.01,"value":120.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant under 2006 Stock and Option Plan, vesting on 2/5/2017, subject to (i) acceleration of 50% of shares upon (a) receiving filing confirmation for an NDA for a combination regimen that includes both ivacaftor and a corrector compound or (b) receiving filing confirmation for an sNDA that would increase the number of patients with CF eligible for ivacaftor monotherapy, and (ii) acceleration of 50% of shares upon (a) the announcement of proof-of-concept data for a drug candidate other than an HCV, cystic fibrosis, influenza or JAK3 inhibition drug candidate or (b) reaching a specified net sales level over a twelve month period for our CF products."}],"balance_after":21751,"source":{"system":"sec-edgar","filing":"0001209191-13-007125","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919113007125/doc4.xml","form_type":"4"}},{"id":490594,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2012-06-13T19:52:35.000Z","date":"2012-06-11","kind":"grant","acquired":true,"shares":72000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 16 quarterly installments beginning on 9/11/2012."}],"balance_after":72000,"derivative":{"exercise_price":55.83,"expiration_date":"2022-06-10","underlying":"Common Stock","underlying_shares":72000},"source":{"system":"sec-edgar","filing":"0001209191-12-033675","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112033675/doc4.xml","form_type":"4"}},{"id":490593,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16473,"kind":"person","name":"Horton Kenneth L","position":1,"cik":"0001552047","reported_name":"Horton Kenneth L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Common Stock","published_at":"2012-06-13T19:52:35.000Z","date":"2012-06-11","kind":"grant","acquired":true,"shares":9667,"price":0.01,"value":96.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock grant vesting in four annual installments beginning on 6/11/2013."}],"balance_after":9667,"source":{"system":"sec-edgar","filing":"0001209191-12-033675","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112033675/doc4.xml","form_type":"4"}}]}